Thalassaemia
NEW PUBLICATION | Short Guide For the Management of TDT (2nd Edition)
News
2 Wochen vor
NEW PUBLICATION | Short Guide For the Management of TDT (2nd Edition)
The 4th edition of the original full-length Guidelines, published in June 2022, includes a full review of the evidence supporting almost each recommendation for physicians to know all the facts…
POLICY NEWS | TIF Issues Statement On The New EU Regulation For Blood, Tissues And Cells
News
Juli 15, 2022
POLICY NEWS | TIF Issues Statement On The New EU Regulation For Blood, Tissues And Cells
This single Regulation, once approved by Member States, will replace all existing EU Directives on Blood, Tissues and Cells and will be equally applicable in the EU territory. The proposal…
NEW WEBINAR | Exploring The Value Of Patient Advocacy For Better Thalassaemia Care
News
April 19, 2022
NEW WEBINAR | Exploring The Value Of Patient Advocacy For Better Thalassaemia Care
The objective of this meeting, which brings together eminent haemoglobinopathies specialists and expert patient advocates from Italy and other countries, is to highlight the pivotal value of advocacy in enabling…
INTERNATIONAL THALASSAEMIA DAY 2022: Be Aware. Share. Care
News
März 26, 2022
INTERNATIONAL THALASSAEMIA DAY 2022: Be Aware. Share. Care
Visit the International Thalassaemia Day (ITD) 2022 page, now LIVE on the TIF website, to discover the idea behind the “Be Aware. Share. Care.“ theme, our fantastic campaign resources, the…
RARE DISEASE DAY 2022 | Raising Awareness For People With Rare Diseases
News
Februar 21, 2022
RARE DISEASE DAY 2022 | Raising Awareness For People With Rare Diseases
Rare Disease Day is the movement on rare diseases, working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease everywhere…
What’s New In Clinical Trials For Thalassaemia/Sickle Cell Disease Drugs And Therapies?
Clinical News
Januar 13, 2022
What’s New In Clinical Trials For Thalassaemia/Sickle Cell Disease Drugs And Therapies?
Many pharmaceutical companies are making remarkable progress in their research into candidate treatments for these diseases and 2022 is expected to be yet another eventful year for haemoglobin disorders! Check…
THALIA 2018-2021: Europe Is Seeing A Surge In Thalassaemia, Project Results Show
News
Dezember 22, 2021
THALIA 2018-2021: Europe Is Seeing A Surge In Thalassaemia, Project Results Show
„Although thalassemia has always been endemic in Europe, especially in southern European countries such as Cyprus, Greece and Italy, the disease now knows no borders and constitutes an increasing health,…
TIF Article: COVID-19 Pandemic Exacerbated Existing Problems With Thalassaemia Care
News
Dezember 21, 2021
TIF Article: COVID-19 Pandemic Exacerbated Existing Problems With Thalassaemia Care
The article discusses how the COVID-19 pandemic has magnified challenges in thalassaemia care worldwide and underscores TIF’s activities throughout the coronavirus outbreak in support of patients with haemoglobinopathies. Hematology Advisor…
TIF Signs Agreement With Resonance Health To Deploy FerriSmart®
News
November 15, 2021
TIF Signs Agreement With Resonance Health To Deploy FerriSmart®
FerriSmart is an AI-driven system for automated real-time measurement of liver-iron concentrate (LIC) in patients, using non-invasive MRI-based technology. Under the Letter of Agreement, TIF will engage with National Thalassaemia…